the atherosclerotic plaque formation and early valve lesions. Both processes seem to be initiated by endothelial injury due to increased mechanical stress, followed by extracellular lipid accumulation in the subendothelial region augmented by the presence of oxidized low-density lipoproteins (LDLs), macrophages and other inflammatory cells, and matrix metalloproteinase, with an additional contribution from the activation of the renin-angiotensin-aldosterone system.
echocardiography in parasternal windows: increased focal echogenicity at the base of the posterior leaflet while visualized in parasternal longand short-axis views. AVCs were determined by irregular cusp thickening and focal hyperechogenicity at their bases in respective projections. Leaflet motion was not impaired in any of the subjects with MACs or AVCs, i.e., there was no turbulence in color Doppler nor increased continuous-wave Doppler gradients and the valve commissures were not fused. 3, 11 CIMT and carotid atherosclerotic lesions were evaluated by ultrasonography of the carotid arteries (Siemens Sequoia 512CE). B-mode carotid ultrasonography was performed with a lineararray transducer. It was manipulated so that the walls of the common carotid artery were parallel to the transducer. A region of 1.5 cm proximal to the carotid bifurcation was identified, and the CIMT of the posterior wall was evaluated as the distance between the luminal-intimal and medial-adventitial interface. The average of the 5 measurements was used for analyses.
Increased CIMT was defined as CIMT exceeding 0.9 mm, while focal CIMT exceeding 1.5 mm was considered as carotid plaque.
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Several atherosclerosis risk factors were assessed on the basis of medical history and laboratory tests, including blood pressure measurement, assessment of the lipid profile and renal function, and collection of data on diabetes, obesity, and smoking.
Hypertension was defined on the basis of the 2013 European Society of Hypertension / European Society of Cardiology (ESC) Guidelines for the management of arterial hypertension,
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when either the mean of at least 2 blood pressure measurements was consistently not lower than 140 mmHg of systolic or 90 mmHg of diastolic blood pressure over at least 2 separate days or when antihypertensive therapy was used.
A lipid-lowering therapy or an LDL cholesterol level of 1.8 mmol/l (70 mg/dl) and higher was regarded as diagnostic for hypercholesterolemia, while triglyceride levels of 1.7 mmol/l (150 mg/dl) and higher, for hypertriglyceridemia.
14 Renal function impairment was assessed on the basis of a decreased glomerular filtration rate (eGFR) of less than 60 ml/min/1.73 m 2 calculated by the Modification of Diet in Renal Disease formula. 15 Diabetes was diagnosed on the basis of the 2013 ESC guidelines. 16 In brief, fasting glycemia equal to or exceeding 7.0 mmol/l (126 mg/dl) on 2 measurements, or 11.0 mmol/l (200 mg/dl) in 1 random blood sample, or the use of hypoglycemic drugs was considered diagnostic. Obesity was diagnosed if the patient's body mass index (BMI) was 30 kg/m 2 and higher.
14 Data on the smoking status was collected and a history of cerebrovascular ischemic episodes was obtained. Ischemic stroke was defined as an episode of neurological dysfunction caused by focal cerebral, spinal, or retinal infarction based on abnormalities on computed tomography or to support the hypothesis that annular calcification is atherosclerotic in nature. 2 It has been suggested that valvular calcification and atherosclerosis are associated only at the early stages, and that the potential link may be linked to abnormal serum osteoprotegerin levels. 5 However, there are substantial differences between the 2 diseases, including the absence of smooth muscle cells and the accumulation of larger amounts of calcium and proteins during valvular calcification compared with atherosclerosis. 6 Moreover, it is not clear why lipid-lowering therapy failed in the studies that were performed to prevent or even slow down the progression of valvular disease.
7-9 This observation is in contrast to the hypothesis of the common etiology and pathophysiology of those processes.
Mitral annular calcifications (MACs) and aortic valve calcifications (AVCs), common findings on routine echocardiography, are reported to be associated with numerous cardiovascular risk factors and are considered minor cardioembolic sources, although no causal relationship with stroke has been confirmed so far.
An association between MACs and AVCs and increased carotid intima-media thickness (CIMT) and carotid atherosclerosis has been reported. 10, 11 Several studies have suggested a relationship between MACs and stroke, but an independent association between AVCs and cerebral infarction has been demonstrated solely in the presence of aortic valve stenosis. 3 Moreover, to our knowledge, there has been no study evaluating the concomitant presence of valvular calcifications in relation to cerebrovascular episodes or cardiovascular risk factors and disease.
The aim of this study was to further investigate whether there is a relationship between mitral and aortic annular calcifications, increased CIMT, and incidence of cerebrovascular ischemic episodes in patients with documented coronary atherosclerosis.
PATIENTS AND METHODS
A group of 127 patients with angiographically confirmed coronary artery disease including stable coronary artery disease and acute myocardial syndromes (68 men and 59 women) and without aortic or mitral valve stenosis was divided into 4 subgroups based on echocardiography: patients with AVCs; patients with MACs; patients with with both aortic valve and mitral annular calcifications (AMVCs); and patients with no valvular calcifications (no-VCs).
Standard transthoracic echocardiography was performed with Acuson Sequoia C512 (Siemens Healthcare, Erlangen, Germany). The parasternal long-axis, apical 4-chamber, 2-chamber, and long-axis projections were obtained. Left atrial diameter and left ventricular end-diastolic and end-systolic diameters were measured. Hemodynamic parameters were obtained with pulsedwave and continuous-wave Doppler ultrasound.
MACs were defined based on the presence of the following features on cross-sectional Differences in variables between the groups were analyzed by the χ 2 test and t test, as appropriate. Logistic regression analysis was performed including demographic and clinical parameters (age, sex, CIMT, carotid plaques, TIA, and stroke). A P value of less than 0.05 was considered statistically significant. RESULTS We studied 127 patients at a median age of 74 years (range, 33-87 years). Baseline demographic, clinical, and laboratory data are presented in TABLE 1. The groups did not differ in terms of age, sex, and most cardiovascular risk factors and medications. The combined prevalence magnetic resonance imaging or other objective evidence in a defined vascular distribution or clinical evidence of such injury based on symptoms persisting at least for 24 h or until death.
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TIA was defined according to the American Stroke Association / American Heart Association consensus as a transient episode of neurological dysfunction caused by focal brain, spinal cord, or retinal ischemia without acute infarction. 17 The exclusion criteria were as follows: atrial fibrillation, prosthetic valve, aortic or mitral stenosis, hemorrhagic cerebral episodes, past noncerebrovascular thromboembolic events, and thrombophilia. 
a MACs vs. AMVCs b AVCs vs. no-VCs c MACs vs. no-VCs
Abbreviations: ACEI -angiotensin-converting enzyme inhibitor, ACS -acute cardiac syndrome, AMVCs -aortic valve and mitral annular calcifications, ARB -angiotensin receptor blocker, ASA -acetylsalicylic acid, AVCs -aortic valve calcifications, BMI -body mass index, CAD -coronary artery disease, CKD -chronic kidney disease, eGFR -estimated glomerular filtration rate, HDL-C -high-density lipoprotein cholesterol, LDL-C -low-density lipoprotein cholesterol, MACs -mitral valve calcifications, no-VC -no valvular calcifications, NSTEMI -non-ST-segment elevation myocardial infarction, STEMI -ST-segment elevation myocardial infarction, TC -total cholesterol, TG -triglycerides no-VC group. In patients with AMVCs, only increased CIMT was observed (TABLE 2) .
Patients with increased CIMT were older (72.5 vs. 66.9 years; P = 0.01) but age was not associated with the incidence of carotid plaques, TIA, or stroke. Sex had no effect on clinical outcome and ultrasound carotid parameters (data not shown).
Univariate analysis showed an association between MACs and AMVCs and increased CIMT (P = 0.001), while aortic calcifications were associated with stroke (P = 0. DISCUSSION We demonstrated the relationship between mitral calcifications and increased CIMT in patients with angiographically confirmed coronary artery disease. Patients with periannular calcification of either mitral or mitral and aortic valves had increased CIMT. Moreover, MACs were associated with the occurrence of carotid plaques, TIA, and stroke, while stroke was more common in the AVC compared with the no-VC group.
Both MACs and AVCs were previously shown to be related to atherosclerosis of the various parts of the vascular bed, such as aortic atheromas and carotid and coronary artery disease.
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Moreover, MACs were shown to be a marker of generalized atherosclerotic disease, while AVCs were linked to a greater plaque burden and more calcified coronary lesions on computed tomography.
18 Several studies have also suggested an association between MACs and stroke, 19, 20 but the relationship of AVCs with cerebral infarction has been demonstrated only in the presence of aortic valve stenosis.
3, 21 It has not been clarified whether there is a causal relationship between AMVCs and stroke or whether AMVCs are markers of an increased risk of stroke based on their association with atherosclerotic vascular disease. As noted above, both MACs and AVCs seem to be associated not only with carotid atherosclerosis but of MACs and AVCs in the study population was 59% (proportions of AVCs, MACs, and AMVCs were 55%, 24%, and 21%, respectively). Compared with the no-VC group, the MAC group had an increased incidence of CIMT, carotid plaques, TIA, and stroke. In the AVC group, CIMT was increased and stroke was more common compared with the of view. Moreover, we did not evaluate the presence of aortic atheroma by transesophageal echocardiography and its potential influence on neurological episodes. Additionally, we did not use multislice computed tomography to confirm that increased echogenicity on echocardiography is caused by valve calcification and not fibrosis.
In conclusion, we demonstrated a relationship between MACs and increased CIMT but not TIA or stroke in patients with angiographically confirmed coronary artery disease. There is no association between the presence of calcifications both on mitral and aortic valves and carotid atherosclerosis.
also with aortic atherosclerotic plaques, especially complex lesions, which are a well-known risk factor for ischemic cerebral events. 10,11,21-23 Moreover, carotid atherosclerosis has been reported to be associated with a higher prevalence of atherosclerotic plaques in the aortic arch; therefore, it constitutes an additional potential source of cerebral embolization. 24 However, our results show that only MACs are independent predictors of carotid wall thickening. We did not confirm the association between MACs or AVCs and cerebrovascular episodes.
There are some arguments to support the hypothesis of the cause and effect relationship between MAVCs and stroke. 20, 25, 26 Mitral annular calcification has been suggested as a possible source of cerebral embolism in the Framingham Study independently of traditional risk factors for stroke, even of atrial fibrillation 27 ; however, MAC found on echocardiography is not considered to be an indication for treatment with anticoagulants. 28 A number of case reports have provided evidence for brain ischemic lesions, overt or clinically silent, resulting from calcific emboli from the aortic valve. [29] [30] [31] [32] [33] Rodriguez et al. 34 demonstrated an association between mitral and aortic annular or valvular calcifications and asymptomatic brain infarcts. They showed that embolization from the left-sided cardiac annular or valvular calcifications can vary from friable calcium deposits to noncalcified (thrombotic) material. However, a causal relationship has not been clarified so far.
Although all heart valves have the same basic histological structure, there are differences between atrioventricular and ventricular outflow valves; for example, the semilunar leaflets of the aortic valve are thinner and operate under conditions of high-velocity blood flow, resulting in higher shear stress compared with the mitral valve. 35 Structural differences overlapping with other risk factors may result in the differences in pathological processes occurring on mitral and aortic leaflets. Thus, we hypothesized that the presence of calcifications on both valves may be associated with higher risk of pathological processes and clinical outcomes.
To our knowledge, we have been the first to evaluate the combined presence of valvular calcifications in relation to cerebrovascular episodes or cardiovascular risk factors and disease. Interestingly, we demonstrated that only the simultaneous presence of valvular calcifications was associated with increased CIMT in univariate analysis. However, this factor was no longer an independent predictor of increased CIMT in multivariate analysis, which might be due to a limited number of patients in the AMVC group.
Our study has several limitations. First, the sample size was small and the study had a retrospective design. Patients were not examined by magnetic resonance imaging and silent stroke could not be analyzed. However, symptomatic stroke is more important from a clinical point
